Author:
Shim Ji-Su,Jin Juhae,Kim Sae-Hoon,Lee Taehoon,Jang An-Soo,Park Chan Sun,Jung Jae-Woo,Kwon Jae-Woo,Moon Ji-Yong,Yang Min-Suk,Lee Jaechun,Choi Jeong-Hee,Shin Yoo Seob,Kim Hee-Kyoo,Kim Sujeong,Kim Joo-Hee,Cho Sang-Heon,Nam Young-Hee,Kim Sang-Hoon,Park So Young,Hur Gyu Young,Kim Sang-Ha,Park Hye-Kyung,Jin Hyun Jung,Lee Jae-Hyun,Park Jung-Won,Yoon Ho Joo,Choi Byoung Whui,Cho Young-Joo,Kim Min-Hye,Kim Tae-Bum
Funder
Korea Health Industry Development Institute
Ewha Womans University
Ministry of Health and Welfare
Subject
Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine
Reference30 articles.
1. Evaluation and management of difficult-to-treat and severe asthma: an expert opinion from the Korean academy of asthma, Allergy and clinical immunology, the working group on severe asthma;Kim;Allergy Asthma Immunol Res,2020
2. Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma;Buendia;J Asthma,2021
3. Cost-effectiveness of tiotropium in elderly patients with severe asthma using real-world data;Hong;J Allergy Clin Immunol Pract,2021
4. Tiotropium bromide step-up therapy for adults with uncontrolled asthma;Peters;N Engl J Med,2010
5. Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status;Kerstjens;Respir Med,2016
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献